Amanote Research
Register
Sign In
A WEE1 Inhibitor Analog of AZD1775 Maintains Synergy With Cisplatin and Demonstrates Reduced Single-Agent Cytotoxicity in Medulloblastoma Cells
doi 10.1021/acschembio.5b00725.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
A Regimen Combining the Wee1 Inhibitor AZD1775 With HDAC Inhibitors Targets Human Acute Myeloid Leukemia Cells Harboring Various Genetic Mutations
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
WEE1 Kinase Inhibitor AZD1775 Has Preclinical Efficacy in LKB1-Deficient Non–Small Cell Lung Cancer
Cancer Research
Cancer Research
Oncology
Proteasome Inhibitor Lactacystin Enhances Cisplatin Cytotoxicity by Increasing Endoplasmic Reticulum Stress-Associated Apoptosis in HeLa Cells
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Connexin 43 Enhances the Cisplatin-Induced Cytotoxicity in Mesothelioma Cells
Restoration of CREB Function Ameliorates Cisplatin Cytotoxicity in Renal Tubular Cells
American Journal of Physiology - Renal Physiology
Urology
Physiology
IKKβ Inhibitor in Combination With Bortezomib Induces Cytotoxicity in Breast Cancer Cells
International Journal of Oncology
Cancer Research
Oncology
Participation of Autophagy in the Cytotoxicity Against Breast Cancer Cells by Cisplatin
Oncology Reports
Medicine
Cancer Research
Oncology
Α-Mangostin Enhances Betulinic Acid Cytotoxicity and Inhibits Cisplatin Cytotoxicity on HCT 116 Colorectal Carcinoma Cells
Molecules
Organic Chemistry
Molecular Medicine
Analytical Chemistry
Theoretical Chemistry
Pharmaceutical Science
Medicine
Drug Discovery
Chemistry
Physical
Integrated Genomic Analysis Identifies the Mitotic Checkpoint Kinase WEE1 as a Novel Therapeutic Target in Medulloblastoma
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
